The Library
Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach
Tools
Mehrabian, Amin, Vakili-Ghartavol, Roghayyeh, Mashreghi, Mohammad, Shokooh Saremi, Sara, Badiee, Ali, Arabi, Leila, Alavizadeh, Seyedeh Hoda, Moosavian, Seyedeh Alia and Jaafari, Mahmoud Reza (2022) Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach. Iranian Journal of Basic Medical Sciences, 25 (3). pp. 302-312. doi:10.22038/IJBMS.2022.60306.13369 ISSN 2008-3866.
|
PDF
WRAP-Preparation-characterization-and-biodistribution-of-glutathione-PEGylated-nanoliposomal-doxorubicin-Mehrabian-2022.pdf - Unspecified Version - Requires a PDF viewer. Available under License Creative Commons Attribution Non-commercial. Download (592Kb) | Preview |
Official URL: https://doi.org/10.22038/ijbms.2022.60306.13369
Abstract
Objective(s): Brain cancer treatments have mainly failed due to their inability to cross the blood-brain barrier. Several studies have confirmed the presence of glutathione (GSH) receptors on BBB’s surface, as a result, products like 2B3-101, which contain over 5% pre-inserted GSH PEGylated liposomal Doxorubicin, are being tested in clinical trials. Here we conducted the PEGylated nanoliposomal Doxorubicin particles that are covalently attached to the glutathione using the post-insertion technique. Compared with the pre-insertion approach, the post-insertion method is notably simpler, faster, and more cost-effective, making it ideal for large-scale pharmaceutical manufacturing.
Materials and Methods: The ligands of the DSPE PEG(2000) Maleimide-GSH were introduced in the amounts of 25, 50, 100, 200, and 400 on the available Caelyx. Following physicochemical evaluations, animal experiments such as biodistribution, fluorescence microscopy, and pharmacokinetics were done.
Results: In comparison with Caelyx, the 200L and 400L treatment arms were the most promising formulations. We showed that nanocarriers containing 40 times fewer GSH micelles than 2B3-101 significantly increased blood-brain barrier penetrance. Due to the expressed GSH receptors on tissues as an endogenous antioxidant, Doxorubicin will likely concentrate in the liver, spleen, heart, and lung in comparison with Caelyx, according to other tissue analyses.
Conclusion: The post-insertion technique was found a successful approach with more pharmaceutical aspects for large-scale production. Moreover, further investigations are highly recommended to determine the efficacy of 5% post-inserted GSH targeted nanoliposomes versus 2B3-101 as a similar formulation with a different preparation method.
Item Type: | Journal Article | ||||||
---|---|---|---|---|---|---|---|
Subjects: | Q Science > QP Physiology R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology |
||||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||||
SWORD Depositor: | Library Publications Router | ||||||
Library of Congress Subject Headings (LCSH): | Brain -- Cancer, Glutathione, Drug delivery systems, Brain -- Cancer -- Chemotherapy, Blood-brain barrier, Drugs -- Physiological transport | ||||||
Journal or Publication Title: | Iranian Journal of Basic Medical Sciences | ||||||
Publisher: | Mashhad University of Medical Sciences (MUMS) | ||||||
ISSN: | 2008-3866 | ||||||
Official Date: | March 2022 | ||||||
Dates: |
|
||||||
Volume: | 25 | ||||||
Number: | 3 | ||||||
Page Range: | pp. 302-312 | ||||||
DOI: | 10.22038/IJBMS.2022.60306.13369 | ||||||
Status: | Peer Reviewed | ||||||
Publication Status: | Published | ||||||
Access rights to Published version: | Open Access (Creative Commons) | ||||||
RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |